Adenoid Cystic Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
The mutational landscape of adenoid cystic carcinoma.
|
23685749 |
2013 |
Adolescent idiopathic scoliosis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
|
30019117 |
2018 |
Memory performance
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.
|
29274321 |
2018 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
|
30019117 |
2018 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
|
22286219 |
2012 |
Liver carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Interestingly, erbb2 interacting protein (ERBB2IP), a known target of miR-23c, was positively regulated by KTN1-AS1 and its restoration reversed KTN1-AS1 knockdown attenuated HCC cell growth.
|
30551364 |
2019 |
Liver carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Notably, ERBB2IP silencing restrained HCC cell proliferation and induced apoptosis.
|
30103114 |
2018 |
Heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
We have recently demonstrated that Erbin is decreased in human heart failure and plays a role as a negative modulator of pathological cardiac hypertrophy.
|
26025865 |
2015 |
Congestive heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
We have recently demonstrated that Erbin is decreased in human heart failure and plays a role as a negative modulator of pathological cardiac hypertrophy.
|
26025865 |
2015 |
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
We used a whole-exomic-sequencing-based approach to demonstrate that tumor-infiltrating lymphocytes (TIL) from a patient with metastatic cholangiocarcinoma contained CD4+ T helper 1 (T(H)1) cells recognizing a mutation in erbb2 interacting protein (ERBB2IP) expressed by the cancer.
|
24812403 |
2014 |
Heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
Erbin(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from heart failure.
|
24711380 |
2014 |
Congestive heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
Erbin(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from heart failure.
|
24711380 |
2014 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
We used a whole-exomic-sequencing-based approach to demonstrate that tumor-infiltrating lymphocytes (TIL) from a patient with metastatic cholangiocarcinoma contained CD4+ T helper 1 (T(H)1) cells recognizing a mutation in erbb2 interacting protein (ERBB2IP) expressed by the cancer.
|
24812403 |
2014 |
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
From the above results, we conclude that LAP2 is widely overexpressed in diverse digestive tract cancers and LAP2β regulates motility of cancer cells and suggest that LAP2β may have utility for diagnostics and therapeutics in digestive tract cancers.
|
22745766 |
2012 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
From the above results, we conclude that LAP2 is widely overexpressed in diverse digestive tract cancers and LAP2β regulates motility of cancer cells and suggest that LAP2β may have utility for diagnostics and therapeutics in digestive tract cancers.
|
22745766 |
2012 |
Carcinoma, Large Cell
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Using immunohistochemistry with antibodies for emerin, lamin A/C, lamin B, and LAP2, we examined 105 lung cancer tissues from 33 small cell lung carcinomas (SCLCs) and 72 non-SCLCs (34 adenocarcinomas, 30 squamous cell carcinomas, and 8 large cell carcinomas).
|
31201505 |
2019 |
Non-alcoholic Fatty Liver Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.
|
28902428 |
2018 |
Cardiomyopathies
|
0.010 |
Biomarker
|
group |
BEFREE |
To test this, we analyzed RNA-Seq datasets, finding novel isoforms or isoform tissue-specificity for: Lap2, linked to cardiomyopathy; Nesprin 2, linked to Emery-Dreifuss muscular dystrophy and Lmo7, that regulates the Emery-Dreifuss muscular dystrophy linked emerin gene.
|
29912636 |
2018 |
Squamous cell carcinoma of skin
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Besides, we validated four other SNPs associated with SCC in the replication set, including rs9689649 in PARK2 gene (P = 2.7 × 10(-6) in combined set; P = 3.2 × 10(-5) in the discovery; and P = 0.02 in the replication), rs754626 in the SRC gene (P = 1.1 × 10(-6) in combined set; P = 1.4 × 10(-5) in the discovery and P = 0.02 in the replication), rs9643297 in ST3GAL1 gene (P = 8.2 × 10(-6) in combined set; P = 3.3 × 10(-5) in the discovery; and P = 0.04 in the replication), and rs17247181 in ERBB2IP gene (P = 4.2 × 10(-6) in combined set; P = 3.1 × 10(-5) in the discovery; and P = 0.048 in the replication).
|
26908436 |
2016 |
Carcinoma, Papillary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In papillary carcinomas (PCs), the nuclear proteins most frequently expressed at high levels were emerin (82 % positive), lamin A/C (64 %), and LAP2 (82 %).
|
26254781 |
2015 |
Cardiac Arrest
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
It was shown recently that, in a patient with metastatic cholangiocarcinoma, CD4 T cells specific for a peptide from a mutated region of ERBB2IP could arrest tumor progression.
|
25710958 |
2015 |
Tumor Progression
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
It was shown recently that, in a patient with metastatic cholangiocarcinoma, CD4 T cells specific for a peptide from a mutated region of ERBB2IP could arrest tumor progression.
|
25710958 |
2015 |
Medullary carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In all medullary carcinomas (MCs), intermediate to high levels of expression of lamin A/C and LAP2 were found.
|
26254781 |
2015 |
Esophageal Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Transcriptional regulation of miR-146b by C/EBPβ LAP2 in esophageal cancer cells.
|
24589738 |
2014 |
Esophageal carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Transcriptional regulation of miR-146b by C/EBPβ LAP2 in esophageal cancer cells.
|
24589738 |
2014 |